BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29038114)

  • 1. Inflammasome-Dependent Cytokines at the Crossroads of Health and Autoinflammatory Disease.
    Van Gorp H; Van Opdenbosch N; Lamkanfi M
    Cold Spring Harb Perspect Biol; 2019 Jan; 11(1):. PubMed ID: 29038114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.
    Ozkurede VU; Franchi L
    Clin Exp Immunol; 2012 Mar; 167(3):382-90. PubMed ID: 22288581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated inflammasome signaling in disease.
    Lamkanfi M; Vande Walle L; Kanneganti TD
    Immunol Rev; 2011 Sep; 243(1):163-73. PubMed ID: 21884175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NLRP3 inflammasome in kidney disease and autoimmunity.
    Hutton HL; Ooi JD; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.
    Manthiram K; Zhou Q; Aksentijevich I; Kastner DL
    Nat Immunol; 2017 Jul; 18(8):832-842. PubMed ID: 28722725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoinflammatory Skin Disorders: The Inflammasomme in Focus.
    Gurung P; Kanneganti TD
    Trends Mol Med; 2016 Jul; 22(7):545-564. PubMed ID: 27267764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammasome and interleukin 1].
    Jéru I; Amselem S
    Rev Med Interne; 2011 Apr; 32(4):218-24. PubMed ID: 20541850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammasome, autoinflammatory diseases, and gout.
    Pétrilli V; Martinon F
    Joint Bone Spine; 2007 Dec; 74(6):571-6. PubMed ID: 17714972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the NLRP3 inflammasome: autoinflammatory diseases reach adolescence.
    Gattorno M; Martini A
    Arthritis Rheum; 2013 May; 65(5):1137-47. PubMed ID: 23400910
    [No Abstract]   [Full Text] [Related]  

  • 10. Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.
    Shwin KW; Lee CR; Goldbach-Mansky R
    Dermatol Clin; 2017 Jan; 35(1):21-38. PubMed ID: 27890235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammasome-mediated autoinflammatory disorders.
    Wilson SP; Cassel SL
    Postgrad Med; 2010 Sep; 122(5):125-33. PubMed ID: 20861596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes.
    Bozkurt Y; Demir A; Erman B; Gül A
    Comput Math Methods Med; 2015; 2015():893507. PubMed ID: 26161132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
    Bettiol A; Lopalco G; Emmi G; Cantarini L; Urban ML; Vitale A; Denora N; Lopalco A; Cutrignelli A; Lopedota A; Venerito V; Fornaro M; Vannacci A; Rigante D; Cimaz R; Iannone F
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dermatologic perspective on autoinflammatory diseases.
    Marzano AV; Damiani G; Genovese G; Gattorno M
    Clin Exp Rheumatol; 2018; 36 Suppl 110(1):32-38. PubMed ID: 29742056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1.
    Keyel PA
    Cytokine; 2014 Sep; 69(1):136-45. PubMed ID: 24746243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain of function mutation and inflammasome driven diseases in human and mouse models.
    Cordero MD; Alcocer-Gómez E; Ryffel B
    J Autoimmun; 2018 Jul; 91():13-22. PubMed ID: 29610014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated Osteoclastogenesis.
    Bhuyan F; de Jesus AA; Mitchell J; Leikina E; VanTries R; Herzog R; Onel KB; Oler A; Montealegre Sanchez GA; Johnson KA; Bichell L; Marrero B; De Castro LF; Huang Y; Calvo KR; Collins MT; Ganesan S; Chernomordik LV; Ferguson PJ; Goldbach-Mansky R
    Arthritis Rheumatol; 2021 Jun; 73(6):1021-1032. PubMed ID: 33314777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasomes and dermatology.
    Sá DC; Festa C
    An Bras Dermatol; 2016; 91(5):566-578. PubMed ID: 27828627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasomes: guardians of cytosolic sanctity.
    Lamkanfi M; Dixit VM
    Immunol Rev; 2009 Jan; 227(1):95-105. PubMed ID: 19120479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.
    Satoh T; Otsuka A; Contassot E; French LE
    Immunotherapy; 2015; 7(3):243-54. PubMed ID: 25804477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.